Holbrook, A. M., E. M. Pullenayegum, S. M. Troyan, M. Nikitovic, and M. A. Crowther. “PERSONALIZED BENEFIT-HARM INFORMATION INFLUENCES PATIENT DECISIONS REGARDING WARFARIN”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 20, no. 3, Nov. 2018, https://jptcp.com/index.php/jptcp/article/view/370.